Searchable abstracts of presentations at key conferences in endocrinology

ea0046p18 | (1) | UKINETS2016

High-grade neuroendocrine tumours of the oesophagus: a single centre experience

Salih Zena , Patrao Ana , Kordatou Zoe , Papaxoinis George , Mansoor Was

Background: High-grade neuroendocrine tumours (HGNETs) of the oesophagus are extremely rare and few cases have been reported worldwide. Here we aim to understand clinical profile, treatment strategy and outcomes for oesophageal HGNETs.Methods: We report a single-centre retrospective review of 21 patients with oesophageal HGNETs treated between 2011–2016. Data on incidence, tumour location, stage at presentation, histopathology, treatment protocol an...

ea0021p56 | Clinical practice/governance and case reports | SFEBES2009

Investigating for Cushing's syndrome in a patient with increased BMI on rifampicin

Ali Mansoor , Andrew Julie , Mbagaya Wycliffe , Orme Steve

A 39-year-old rugby league player was admitted with back pain to an Endocrinology/General Medicine ward. He was diagnosed with osteomyelitis of the spine and was treated with antibiotic. During his prolonged in-patient stay (6 weeks i.v. antibiotic treatment), the presence of purple striae on his lower abdomen was noted. Although he did not have other classical features of a Cushing’s syndrome including proximal myopathy, he had an increased BMI (38 kg/m2) and ...

ea0074ncc30 | Highlighted Cases | SFENCC2021

The management of ectopic ACTH syndrome secondary to a lung neuro-endocrine tumour with metyrapone: Illustration from a clinical case

Kapoor Ashutosh , Latchford Charles , Chatzimavridou Victoria , Mansoor Wasat , Adam Safwaan

Case history: We report the case of a previously healthy 69-year-old female who was referred to our centre after she presented with rapidly progressive weight-gain, hyperglycaemia, hypokalaemia and hypertension. She had no symptoms suggestive of carcinoid syndrome. On assessment, she had pathognomonic features of Cushing’s syndrome: central weight gain (peripheral wasting) proximal myopathy, leg oedema, skin thinning, bruising and facial puffiness; this appearance being m...

ea0082wd2 | Workshop D: Disorders of the adrenal gland | SFEEU2022

Addison”s disease in individual living with HIV: is Covid-19 the culprit?

Soo Choi Ji , Mital Dushyant , H Ahmed Mohamed , Mansoor Raza Mohamed

Introduction: There are emerging reports showing the relationship between human immunodeficiency virus (HIV), Covid-19 and adrenal insufficiency. This was attributed to thrombotic events and necrosis, leading to hypoadrenalism. The HIV virus can also lead to Addison”s disease due to destruction of adrenal gland. Prevalence of adrenal infarction with COVID-19 was found to be 23% and 88% this was shown to be affecting both adrenal glands. Case report:...

ea0068p14 | Abstracts | UKINETS2019

Liver embolisation for patients diagnosed with neuroendocrine neoplasms: systematic review and meta-analysis of the literature

Kanabar Rahul , Barriuso Jorge , McNamara Mairead , Mansoor Was , Hubner Richard , Valle Juan , Lamarca Angela

Background: Liver embolisation is one of the treatment options available for patients diagnosed with neuro-endocrine neoplasms (NEN), especially in the presence of carcinoid syndrome. It is still uncertain whether the benefits of the various types of embolisation treatments truly outweigh the complications in NENs. This systematic review assesses the available data relating to liver embolisation in patients with NENs.Methods: Eligible studies (identified...

ea0067o31 | Oral Presentations | EYES2019

Onset of radiation-induced hypopituitarism in pituitary adenomas

Seejore K , Tudawe G , Mansoor T , Lynch JM , Orme SM , Phillips N , Loughrey C , Murray RD

Objective: Radiotherapy (RT) can achieve tumour control rates of over 90% in pituitary adenomas. The commonest toxicity of irradiation is hypopituitarism. The exact incidence is variable and requires long-term testing for deficiency of all hypothalamic-pituitary axes (HPA). The aim of this study is to determine the time to onset of individual hormonal deficiencies and establish a timeframe for endocrine testing post-RT.Methods: We retrospectively assesse...

ea0046p21 | (1) | UKINETS2016

Efficacy of the combination of Capecitabine and Temozolamide in patients with advanced Pulmonary Carcinoid Tumors: A single institution experience

Kordatou Zoe , Papaxoinis George , McCallum Lynn , Salih Zena , Nasralla Magdy , Nonaka Daisuke , Mansoor Wasat

Background: Pulmonary carcinoids (PC) are rare neuroendocrine tumors (NETs). The course of PCs is considered to be indolent, but patients with advanced disease have low survival rates and their treatment options are limited. As PCs are under-represented in trials, therapeutic decisions are based on evidence extrapolated from other types of NETS. Capecitabine-Temozolamide (CAPTEM) has demonstrated significant efficacy in pancreatic NETs. However, its role in PCs is still unexpl...

ea0029p1574 | Thyroid (non-cancer) | ICEECE2012

Adaptation of the hypothalamo-pituitary-thyroid axis to pubertal development and exposure to acute and chronic physical stresses

Younus A. , Naseem A. , Aslam S. , Irfan M. , Tahir F. , Qayyum M. , Mansoor R. , Murtaza S. , Rizvi S.

The hypothalamo-pituitary-thyroid axis undergoes adaptive changes in response to increased energy expenditure at puberty, a process called thyroidarche. Furthermore, the secretion of thyroid hormones (THs) is influenced by various kinds of acute and chronic stresses. Amongst others, persistent and severe physical stress may affect the secretion of THs. The present study investigates changes in the secretion of thyrotropin releasing hormone (TSH), trioiodothyronine (T3) and tet...

ea0087oc3 | Oral Communications | UKINETS2022

Outcomes in patients with advanced well-differentiated gastroenteropancreatic neuroendocrine tumours receiving PRRT early versus later

Robinson Matthew D , Chander Amarjot , Westwood Tom , Manoharan Prakash , Mansoor Was , Lamarca Angela , A Hubner Richard , W Valle Juan , G McNamara Mairead

Background: Neuroendocrine tumours (NETs) are rare malignancies; over 60% of primary lesions arise in the gastrointestinal tract and pancreas. Despite several practice-changing clinical trials, uncertainty persists around the most efficacious treatment sequence in patients with advanced well-differentiated gastroenteropancreatic (GEP) NETs, particularly in relation to peptide receptor radionuclide therapy (PRRT). This study aimed to investigate the progression-free survival (P...

ea0068p6 | Abstracts | UKINETS2019

Hepatic arterial embolisation for patients diagnosed with neuroendocrine neoplasms: experience from a European Neuroendocrine Tumour Society centre of excellence

Nuttall Christina , Lamarca Angela , McNamara Mairead , Barriuso Jorge , Lawrance Jeremy , Mullan Damian , Mansoor Was , Valle Juan , Hubner Richard

Background: Hepatic arterial embolisation (HAE) is a recommended treatment option for patients with neuro-endocrine neoplasms (NENs) and liver metastasis. We aimed to describe outcomes after HAE for NENs at a single United Kingdom centre and investigate the influence of tumour characteristics.Methods: Retrospective analysis of sequential patients with NENs undergoing HAE at The Christie NHS Foundation Trust between 2004 and 2018. Primary end points were ...